Company intelligence / Profile preview

Ars Arthro

Ankara, Ankara, Turkey

Ownership: Private
Development stage: Other

Overview

Ars Arthro Biotechnology is a Turkish biotechnology company specializing in regenerative medicine and tissue engineering. Founded in 2005 through a technology transfer from the German firm Ars Arthro GmbH, the company focuses on autologous cell therapies for orthopedic and dermatological applications. Its flagship products include the CaReS (Cartilage Regeneration System) for joint cartilage repair and Fibrocell, an autologous fibroblast therapy for skin rejuvenation and wound healing. Ars Arthro operates a GMP-certified production facility in Ankara, Turkey, where it develops advanced biological treatments based on research originally conducted within the Fraunhofer Group.

Therapeutic areas: RheumatologyDermatology
Modalities: Cell therapyTissue engineeringBiologicDevice
Industry: Biotech

Partnerships

Fraunhofer GroupArthro Kinetics

Beyond the preview

Go deeper on Ars Arthro.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ars Arthro.

Explore the full profile